La Jolla Institute for Allergy & Immunology:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:La Jolla Institute for Allergy & Immunology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9345
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
La Jolla Institute for Allergy & Immunology (LIAI) is a biomedical research institute that offers solutions for infectious agents and cancers. The institute provides research on prevention, treatment, and cure of immune system diseases. Its activities include disease research on allergy and asthma, cancer, diabetes, infectious disease, inflammation biology, microbiology and immunology, and RNAi research. LIAI also offers autoimmune research on rheumatoid arthritis, type 1 diabetes, multiple sclerosis and Crohn’s disease, among others. The institute operates through various research centers located across the US. LIAI is headquartered in La Jolla, California, the US.

La Jolla Institute for Allergy & Immunology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
La Jolla Institute for Allergy & Immunology, Medical Devices Deals, 2012 to YTD 2018 9
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Bioneer Enters Into Research Agreement with La Jolla Institute for Allergy and Immunology 11
La Jolla Institute Enters Into Agreement With Kyowa Hakko Kirin California For Drug Discovery 12
Licensing Agreements 13
Turnstone Biologics Enters into Licensing Agreement with La Jolla Institute for Allergy and Immunology 13
Equity Offering 14
CHIME BioTherapeutics Spin-Off from La Jolla Institute for Allergy and Immunology 14
La Jolla Institute for Allergy & Immunology – Key Competitors 15
La Jolla Institute for Allergy & Immunology – Key Employees 16
La Jolla Institute for Allergy & Immunology – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Apr 12, 2018: LJI Researchers are One Step Closer to an Effective Anti-Atherosclerosis Vaccine 18
Product News 19
Oct 26, 2017: Vanderbilt leads international effort to develop universal flu vaccine 19
Jun 20, 2017: San Diego team tests best delivery mode for potential HIV vaccine 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Key Facts 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
La Jolla Institute for Allergy & Immunology, Deals By Therapy Area, 2012 to YTD 2018 8
La Jolla Institute for Allergy & Immunology, Medical Devices Deals, 2012 to YTD 2018 9
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bioneer Enters Into Research Agreement with La Jolla Institute for Allergy and Immunology 11
La Jolla Institute Enters Into Agreement With Kyowa Hakko Kirin California For Drug Discovery 12
Turnstone Biologics Enters into Licensing Agreement with La Jolla Institute for Allergy and Immunology 13
CHIME BioTherapeutics Spin-Off from La Jolla Institute for Allergy and Immunology 14
La Jolla Institute for Allergy & Immunology, Key Competitors 15
La Jolla Institute for Allergy & Immunology, Key Employees 16

List of Figures
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
La Jolla Institute for Allergy & Immunology, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[La Jolla Institute for Allergy & Immunology:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fortis Inc.:企業の戦略・SWOT・財務情報
    Fortis Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortis Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Quantum Fuel Systems LLC:企業の戦略的SWOT分析
    Quantum Fuel Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Orezone Gold Corporation:企業の戦略・SWOT・財務情報
    Orezone Gold Corporation - Strategy, SWOT and Corporate Finance Report Summary Orezone Gold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Japan Tobacco Inc (2914):製薬・医療:M&Aディール及び事業提携情報
    Summary Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes. It also manufactures, markets and sells varied pharmaceutical and processed food products such as frozen cooked rice and noodles, instant noodles, bread and frozen bread, mineral water, and seasoning, p …
  • BASF SE (BAS)-製薬・医療分野:企業M&A・提携分析
    Summary BASF SE (BASF) is a chemical company, which carries out research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additives, e …
  • Fichtner GmbH & Co KG:企業の戦略的SWOT分析
    Fichtner GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Okinawa Cellular Telephone Company (9436):企業の財務・戦略的SWOT分析
    Okinawa Cellular Telephone Company (9436) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • REV Group, Inc. (REVG):企業の財務・戦略的SWOT分析
    REV Group, Inc. (REVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Liberty Insurance Berhad:企業の戦略・SWOT・財務情報
    Liberty Insurance Berhad - Strategy, SWOT and Corporate Finance Report Summary Liberty Insurance Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Tanfield Group PLC (TAN):企業の財務・戦略的SWOT分析
    Summary Tanfield Group plc (Tanfield Group) is an investment company that offers electrical investments. The company designs and produces electric commercial vehicles for short haul urban fleets. It also produces zero-emission vehicles that deliver better performance to traditional diesel trucks. Ta …
  • Bunzl plc (BNZL):医療機器:M&Aディール及び事業提携情報
    Summary Bunzl plc (Bunzl) is a global distribution and outsourcing company. The company offer its customers with a unique business concept, which provides individual solutions along the supply chain to a variety of businesses and numerous goods around the world. It supplies a broad range of non-food …
  • Reinsurance Group of America Inc:企業の戦略・SWOT・財務分析
    Reinsurance Group of America Inc - Strategy, SWOT and Corporate Finance Report Summary Reinsurance Group of America Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Barclaycard:企業の戦略・SWOT・財務分析
    Barclaycard - Strategy, SWOT and Corporate Finance Report Summary Barclaycard - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • NAPEC Inc. (NPC)-エネルギー分野:企業M&A・提携分析
    Summary NAPEC Inc. (NAPEC), formerly CVTech Group Inc., is an energy services company that provides construction and maintenance services. It builds and maintains electrical transmission and distribution systems, solar panel farms, and natural gas networks. The company installs gas-powered and elect …
  • Otonomy Inc (OTIC):企業の財務・戦略的SWOT分析
    Otonomy Inc (OTIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • FAR Ltd (FAR):石油・ガス:M&Aディール及び事業提携情報
    Summary FAR Ltd (FAR), formerly First Australian Resources NL, is an independent oil and gas company that offers acquisition, exploration, production and development of oil and natural gas properties. The company has oilfield appraisal wells and exploration assets in West and East Africa. It operate …
  • Beach Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Beach Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Beach Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the o …
  • Servair:企業の戦略・SWOT・財務分析
    Servair - Strategy, SWOT and Corporate Finance Report Summary Servair - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • HNB Assurance PLC (HASU.N0000):企業の財務・戦略的SWOT分析
    HNB Assurance PLC (HASU.N0000) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Arab Petroleum Investments Corp:企業の戦略的SWOT分析
    Arab Petroleum Investments Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆